Innovate Biopharmaceuticals Inc (NASDAQ:INNT) shares passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.58 and traded as high as $0.73. Innovate Biopharmaceuticals shares last traded at $0.71, with a volume of 1,935,361 shares trading hands.
The firm has a market capitalization of $29.34 million, a PE ratio of -1.08 and a beta of -0.39. The business’s 50 day moving average is $0.58 and its two-hundred day moving average is $0.55.
About Innovate Biopharmaceuticals (NASDAQ:INNT)
Innovate Biopharmaceuticals, Inc, a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company's lead product candidate is INN-202 that has completed Phase IIb clinical trial for the treatment of celiac disease. It also develops INN-108, which has completed Phase I clinical trial to treat mild-to-moderate ulcerative colitis; INN-217 for the treatment of non-alcoholic steatohepatitis and microbiome; and INN-289 to treat crohn's disease, as well as product for the treatment of alcoholic steatohepatitis (ASH).
Further Reading: Federal Reserve
Receive News & Ratings for Innovate Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovate Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.